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The molecular mechanisms by which differentiated cells
combat cell death and injury have remained unclear. In
the current issue, it has been shown in neurons that cell
differentiation is accompanied by a decrease in Apaf-1
and the activity of the apoptosome with an increased
ability of the inhibitor of apoptosis proteins (IAPs) to sus-
tain survival (Wright et al., 2004). These results, together
with earlier ones, deepen our understanding of how cell
death and the apoptosome are regulated during differen-
tiation and in tumor cells.
 
Apoptosis and its dysfunction play a crucial role in different
human diseases, such as cancer and neurological degenerative
disorders. Cell suicide is regulated by both extra- and intra-
cellular factors that activate conserved cellular processes. The
intrinsic pathway involving mitochondria is especially interest-
ing with the participation of molecules both upstream and
downstream of the organelle. The complexity of this pathway
allows for the strict regulation of cell death and provides the
possibility for intervention both at the pre- and post-mitochon-
drial level.
Proteins of the Bcl-2 family are major determinants of
cell viability, controlling the mitochondrial membrane pore
formation induced by different death signals converging on the
organelle (Danial and Korsmeyer, 2004). Following an in-
crease in the permeability of the outer membrane, cytochrome
 
c
 
 and other pro-apoptotic proteins are released from the inter-
membrane space triggering cell demise (Lindholm et al., 2004).
In the cytosol, a complex known as the apoptosome is formed
from apoptotic protease activating factor-1 (Apaf-1), procas-
pase-9, and cytochrome 
 
c
 
/dATP. 
 
Apaf-1
 
 resembles the 
 
C.
elegans 
 
protein CED-4 that is required for apoptosis in the
worm (Li et al., 1997; Zhou et al., 1997). Apaf-1 has a caspase
recruitment domain (CARD) that allows it to bind to the
CARD in caspase 9, a central P loop motif that binds ATP,
and at the COOH terminus are WD40 repeats that bind to
cytochrome 
 
c
 
 (Fig. 1). Oligomerization of Apaf-1 leads to
autoactivation of procaspase-9 that in turn cleaves caspase-3,
ultimately causing cell death (Acehan et al., 2002; Hill et al.,
2004). The structure of the apoptosome thus constitutes a cellular
“death wheel” (Fig. 1).
Wright et al. (2004) show that the activity of the apopto-
some changes with neuronal differentiation with alterations in
both Apaf-1 and the efficacy of the IAPs. IAPs contain one
to three well-conserved domains, the so called baculovirus
IAP repeats (BIR). Via its BIRs, X chromosome–linked IAP
(XIAP) can bind processed caspase-9 and -3, and can in turn be
inhibited by proteins, such as Smac/Diablo released from the
mitochondria during cell death (Du et al., 2000; Fig. 1). Over-
expression of XIAP can protect cells against different death
stimuli (Perrelet et al., 2002; Trapp et al., 2003), but the role of
endogenous IAPs is unclear as neither gene deletion of XIAP
or Smac/Diablo showed any abnormality in apoptosis (Harlin
et al., 2001; Okada et al., 2002).
The biology of the apoptosome has been studied mainly
in cell-free systems, and less in living cells. Wright et al.
(2004) now demonstrate that during differentiation of PC12
cells or primary sympathetic neurons, the level of Apaf-1 is re-
duced and the protective activities of IAPs are increased. This
explains earlier observations that cytoplasmic cytochrome 
 
c
 
was not able to trigger death of sympathetic neurons, although
it was sufficient to kill nonneuronal cells (Deshmukh et al.,
2002; Potts et al., 2003). The levels of Apaf-1 are high in non-
differentiated PC-12 cells and sympathetic neurons, but drop
dramatically during neuronal differentiation, and this reduction
renders the mature neurons resistant to cytochrome 
 
c
 
–triggered
apoptosis. The authors also show that reduction in the level of
Apaf-1 is accompanied by increased protection by the IAPs.
Although there was no change in the amounts of IAPs or cas-
pase-9, Apaf-1 levels and apoptosome activity were reduced,
allowing for more effective regulation by the IAPs. Consistent
with this outcome, Vyas et al. (2004) recently showed that dif-
ferentiated PC12 cells have increased resistance to cell death
that is IAP dependent.
Does this only apply to neuronal cells? Wright et al.
(2004) show that cytochrome 
 
c
 
 induces rapid caspase activation
in the lysates of differentiated primary fibroblasts, as is seen in
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undifferentiated nerve cells. Thus, in dividing nonneuronal
cells, the high Apaf-1 levels keep the activity of the IAPs low.
Also, regulation of cell death by the IAPs seems blunted in
many mitotic compared with postmitotic cells. In Apaf-1 het-
erozygous fibroblasts, however, the lowered levels of Apaf-1
enhanced the activity of IAPs, as in the differentiated neurons.
Although the findings refer to postmitotic normal cells,
they may have implications for abnormal cells. Small molecu-
lar compounds targeting XIAP can lead to activation of cas-
pases and induction of cell death of tumors (Schimmer et al.,
2004). In many cancer cells, the brake exerted by the IAPs is
strong enough to counteract cell death. In view of the present
findings of a strict correlation between Apaf-1 and the action of
XIAP in cell differentiation, it would be interesting to study
whether Apaf-1 might be an additional target to consider in
cancer therapies. In this case, Apaf-1 may be elevated by en-
hancing transcription of the gene or possibly by influencing the
stability/post-transcriptional modifications of the protein.
Apart from Apaf-1/IAPs, other molecules may influence
cell death at the level of the apoptosome. In this respect, a
novel factor was recently cloned, named Apaf-1 interacting
protein (AIP). It is expressed in brain tissue and is able to pro-
tect neurons after ischemia/stroke (Cao et al., 2004). AIP con-
tains only the NH
 
2
 
-terminal CARD domain and constitutes a
dominant-negative inhibitor of the activity of the Apaf-1–cas-
pase-9 complex. Changes in expression of AIP by cell differen-
tiation or in tumor cells have so far not been reported.
Although there is a partial requirement for Apaf-1 for de-
velopmental neuronal apoptosis (Cecconi et al., 1998; Yoshida
et al., 1998; Cozzolino et al., 2004), loss of Apaf-1 does not
prevent all types of cell death, as is evident in lymphoid cells
lacking both Apaf-1 and caspase-9 (Marsden et al., 2002). In
the absence of the apoptosome, apoptosis did not occur in inter-
leukin-3–dependent myeloid cells but the number of cells that
eventually died following death stimuli was unaltered (Ekert et
al., 2004). Deprivation of neurons of trophic factors usually
triggers the mitochondrial death pathway and activation of the
apoptosome. Differentiated neurons with low levels of Apaf-1
and reduced apoptosome activity die also when challenged by
different factors or in neurodegenerative diseases. Whether this
still involves Apaf-1–mediated cell death or contributions from
other factors is unknown. Cellular pathways, not primarily
involving mitochondria and the apoptosome complex, are
probably also activated in differentiated brain cells. Thus,
sympathetic neurons die through a nonmitochondrial, but still
caspase-dependent, pathway in the absence of glial cell line–
derived neurotrophic factor (Yu et al., 2003).
In conclusion, Wright et al. (2004) reveal many important
aspects of neuronal apoptosis, but also raise further questions.
It would be interesting to know what makes the IAPs more effi-
cient protectors in the differentiated neurons. Is this achieved
by the mere reduction in Apaf-1 levels, or is there a closer asso-
ciation between these proteins in the cell involving some feed-
back mechanisms? The work nicely connects the regulation of
Apaf-1 and the functional state of the IAPs with cell differenti-
ation. However, there is certainly more to be learned about how
cell death is regulated in normal, differentiated, and highly pro-
liferating tumor cells. In view of this, the wheel to more in-
sights is still spinning.
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